Share on LinkedInShare on LinkedIn

ARTICLE · 07 APRIL 2015

Capital Markets Report - March 2015

Cassels
Cassels
Contributor
Cassels

Cassels

Cassels Brock & Blackwell LLP is a Canadian law firm focused on serving the transaction, advocacy,...

View firm profile
Explore more from Cassels

Guidance would be relevant to any issuer that is changing its business as this notice provides an example of the level of disclosure the regulators would expect.

CanadaCorporate/Commercial Law

Covering the period February 1 - 28, 2015

FROM THE REGULATORS

NEWS AND NOTICES

CSA Provides Guidance on Disclosure Requirements of Medical Marijuana Businesses

By: Justin Dick, Jessica Lee and Kyle Simpson

Guidance would be relevant to any issuer that is changing its business as this notice provides an example of the level of disclosure the regulators would expect.

On February 23, 2015, on behalf of the Canadian Securities Administrators (the "CSA"), staff from the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission and the Autorité des marchés financiers (the "Staff") released Staff Notice 51-342 Staff Review of Issuers Entering Into Medical Marijuana Business Opportunities (the "Notice"). The Notice is the result of the Staff's review of certain reporting issuers that had publicly announced their intention to enter into Canada's medical marijuana industry and whether they were providing sufficient

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from